1. Home
  2. VSME vs LIXT Comparison

VSME vs LIXT Comparison

Compare VSME & LIXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VSME
  • LIXT
  • Stock Information
  • Founded
  • VSME 2013
  • LIXT 2005
  • Country
  • VSME Hong Kong
  • LIXT United States
  • Employees
  • VSME N/A
  • LIXT N/A
  • Industry
  • VSME
  • LIXT Biotechnology: Pharmaceutical Preparations
  • Sector
  • VSME
  • LIXT Health Care
  • Exchange
  • VSME Nasdaq
  • LIXT Nasdaq
  • Market Cap
  • VSME 4.2M
  • LIXT 4.1M
  • IPO Year
  • VSME 2023
  • LIXT N/A
  • Fundamental
  • Price
  • VSME $1.20
  • LIXT $2.33
  • Analyst Decision
  • VSME
  • LIXT
  • Analyst Count
  • VSME 0
  • LIXT 0
  • Target Price
  • VSME N/A
  • LIXT N/A
  • AVG Volume (30 Days)
  • VSME 683.7K
  • LIXT 18.9K
  • Earning Date
  • VSME 12-23-2024
  • LIXT 11-12-2024
  • Dividend Yield
  • VSME N/A
  • LIXT N/A
  • EPS Growth
  • VSME N/A
  • LIXT N/A
  • EPS
  • VSME N/A
  • LIXT N/A
  • Revenue
  • VSME $8,488,339.00
  • LIXT N/A
  • Revenue This Year
  • VSME N/A
  • LIXT N/A
  • Revenue Next Year
  • VSME N/A
  • LIXT N/A
  • P/E Ratio
  • VSME N/A
  • LIXT N/A
  • Revenue Growth
  • VSME 3.15
  • LIXT N/A
  • 52 Week Low
  • VSME $0.65
  • LIXT $1.31
  • 52 Week High
  • VSME $6.16
  • LIXT $4.40
  • Technical
  • Relative Strength Index (RSI)
  • VSME 51.19
  • LIXT 54.46
  • Support Level
  • VSME $1.04
  • LIXT $2.25
  • Resistance Level
  • VSME $1.20
  • LIXT $2.68
  • Average True Range (ATR)
  • VSME 0.23
  • LIXT 0.23
  • MACD
  • VSME -0.01
  • LIXT 0.01
  • Stochastic Oscillator
  • VSME 21.05
  • LIXT 53.90

About VSME VS Media Holdings Limited

VS Media Holdings Ltd manages a global network of digital Creators who create and publish content to social media platforms such as YouTube, Facebook, Instagram, and TikTok. Its Creators include influencers, KOLs-Key Opinion Leaders, bloggers, and other content creators who cultivate fanbases on social media platforms. The company's business provides value to two major business stakeholders: Creators and Brands. Its Value to Creators: It empowers and supports Creators by providing them with production facilities, training, and funding to produce quality content. Its Value to Brands: the company bridges the divide between Brands and Creators by helping Brands reach their target audience effectively by advising on content strategy and budget and recommending specific Creators.

About LIXT Lixte Biotechnology Holdings Inc.

Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.

Share on Social Networks: